Wellington Management Group’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Wellington Management Group's ANAB Position: Q2 2026 in Review
Wellington Management Group reduced its AnaptysBio (ANAB) stake by 11% in Q2 2026, selling an estimated $308K and leaving 41,796 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1556.
Wellington Management Group first reported a position in ANAB in Q1 2018 and has held it in 17 quarters since. The position peaked at $2.97M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Wellington Management Group held 41,796 shares of AnaptysBio worth $2.82M as of Q2 2026.
- Wellington Management Group sold 5,085 AnaptysBio shares in Q2 2026, an estimated $308K.
- AnaptysBio made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1556 holding.
- Wellington Management Group first reported a position in AnaptysBio in Q1 2018 and has held it in 17 quarters since.
- Wellington Management Group's AnaptysBio position peaked at $2.97M in Q4 2025.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.